Category: Health

Category: Health

DAGOMO Water Research survey

DAGOMO Foundation Nigeria, a non-governmental organisation in the ageing space has as its mission to be a bridge in society connecting the disadvantaged, unheard and unrecognized with opportunities for a more fulfilled life. Our approach to achieve this is by being a catalyst for positive change through ageing research, developing ageing policy and promoting ageing advocacy. As part of our research objectives, we have carried out a research on assessment of adequate water intake among middle aged and older adults in three states; Abuja, Edo and Lagos, where we currently have operational offices.

Click the link to download the Research document: Download here

World Hepatitis Day

World Hepatitis Day is commemorated each year on 28 July to enhance awareness of viral hepatitis, an inflammation of the liver that causes a range of health problems, including liver cancer.

There are five main strains of the hepatitis virus – A, B, C, D and E. Together, hepatitis B and C are the most common cause of deaths, with 1.3 million lives lost each year. Amid the COVID-19 pandemic, viral hepatitis continues to claim thousands of lives every day.

This year’s theme is “Hepatitis-free future,” with a strong focus on preventing hepatitis B among mothers and newborns. Last year, the theme of World Hepatitis Day was ‘Invest in eliminating hepatitis’.

Hepatitis C Facts

Hepatitis C is a liver disease caused due to hepatitis C virus (HCV): the virus is capable of causing both acute and chronic hepatitis, varying in severity from a mild illness lasting a few weeks to a serious, lifetime illness. Hepatitis C is a major cause of liver cancer.

Hepatitis C virus is a bloodborne virus: It is mostly caused by getting infected through exposure to small quantities of blood. Reasons such as injection drug use, unsafe injection practices, unsafe health care, transfusion of unscreened blood and blood products, and sexual practices often leading to exposure to blood.

An estimated 71 million people have chronic hepatitis C virus infection globally.

Most of those who are chronically infected will develop cirrhosis or liver cancer.

Antiviral medicines are capable of curing more than 95% of persons with hepatitis C infection, therefore reducing the risk of death from cirrhosis and liver cancer, but access to diagnosis and treatment remains low.

Till now, no effective vaccine against hepatitis C has been made; nevertheless, research is being carried out.